Clinical Trial Update: Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a biologically optimized infusion schedule of gemcitabine and nab-paclitaxel for metastatic pancreatic cancer, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Anne Noonan | Conditions: Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | Status: RECRUITING